Quest diagnostics reports third quarter 2024 financial results; updates guidance for full year 2024

Third quarter revenues of $2.49 billion, up 8.5% from 2023 third quarter reported diluted earnings per share ("eps") of $1.99, up 1.5% from 2023; and adjusted diluted eps of $2.30, up 3.6% from 2023 full year 2024 revenues now expected to be between $9.80 billion and $9.85 billion; reported diluted eps now expected to be between $7.60 and $7.70; and adjusted diluted eps expected to be between $8.85 and $8.95 secaucus, n.j. , oct. 22, 2024 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), a leading provider of diagnostic information services, today announced financial results for the third quarter ended september 30, 2024.
DGX Ratings Summary
DGX Quant Ranking